Join the club for FREE to access the whole archive and other member benefits.

MitoRx Therapeutics' CEO shares insights on fundraising and pitching to investors

Effectively communicating to investors will translate an ideology into a social benefit

20-Jul-2022

Key points from article :

Jon Rees unveiled early-stage pitching advice, success tips, and MitoRx’s further steps.
Change the tone of the conversations to make proposition relatable to investors.
Prioritise development programmes to the commercial opportunity.
Initial communication with investors must include exact stage, lead indication, money you’re raising, and your aim.
If you believe in what you’re doing, you had better make sure they feel that in the initial meeting!
We can completely protect mitochondria from oxidative stress of biological origin in a mammalian system.
If you set out to develop a medicine that has a large, clinically meaningful effect, then financial profits will follow.
Conviction from the founders is also essential.
When we validated our hypothesis at MitoRx, we approached investors with extremely high levels of conviction.
We know and believe that we can almost completely protect cells in disease-related stress.
Our aim is to arrest the progression of diseases driven by mitochondrial dysfunction.

Mentioned in this article:

Click on resource name for more details.

Jon Rees

CEO and co-founder at MitoRx Therapeutics

MitoRx Therapeutics

Pre-clinical stage rare disease biotech company aiming to develop treatments for degenerative diseases

Topics mentioned on this page:
Investments, Mitochondria
MitoRx Therapeutics' CEO shares insights on fundraising and pitching to investors